Axsome Therapeutics, Inc. (AXSM)
196.03
+2.58
(+1.33%)
USD |
NASDAQ |
Sep 24, 16:00
196.99
+0.96
(+0.49%)
After-Hours: 19:59
Axsome Therapeutics Gross Profit (Annual) : 581.95M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 581.95M |
| December 31, 2024 | 344.43M |
| December 31, 2023 | 237.70M |
| December 31, 2022 | 39.28M |
| December 31, 2021 | -1.156M |
| December 31, 2020 | -0.0777M |
| December 31, 2019 | -0.0373M |
| Date | Value |
|---|---|
| December 31, 2018 | -0.0489M |
| December 31, 2017 | -0.0426M |
| December 31, 2016 | -0.0205M |
| December 31, 2015 | -0.0035M |
| December 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Eli Lilly & Co. | 54.13B |
| Liquidia Corp. | 144.25M |
| Filana Therapeutics, Inc. | -0.936M |
| CorMedix, Inc. | 275.75M |
| Eloxx Pharmaceuticals, Inc. | 0.00 |